Dosed like a smaller man: why women get the wrong drug doses

For most of modern medical history, the default clinical research subject was a man. Doses were tested on male bodies, and women were assumed to be smaller versions of the same system. They aren't.

The correction that made it undeniable

In 2013, the FDA cut the recommended dose of zolpidem — the active ingredient in Ambien — in half, for women only. Women metabolize the drug more slowly, and at the standard dose many still had enough in their bloodstream the next morning to impair driving. The drug had been on the market for over twenty years before the dosing caught up with female physiology.

Why the difference is real

It isn't just body size. Women differ in body composition (which changes how drugs distribute), in liver enzyme activity (which changes how fast compounds are metabolized), and in hormonal cycles that interact with everything from pain response to drug clearance. Reviews of approved medications have repeatedly found that women experience adverse drug reactions significantly more often than men — a predictable outcome of dosing built on male baselines.

Why we talk about this

This history is the reason Seya exists. We believe formulas for women should start from female physiology — metabolism, hormones, body composition — not from a male standard scaled down. It's also why we encourage every woman to ask her provider a simple question: "was this dose studied in women?"

† This article is for general information only and is not medical advice. These statements have not been evaluated by the Food and Drug Administration. Always talk to a qualified healthcare provider about your health.